Literature DB >> 12050488

Effects of extracorporeal shock wave lithotripsy on plasma levels of nitric oxide and cyclic nucleotides in human subjects.

Jong Kwan Park1, Yong Cui, Myung Ki Kim, Young Gon Kim, Suhn Hee Kim, Sung Zoo Kim, Kyung Woo Cho.   

Abstract

PURPOSE: The role of extracorporeal shock wave lithotripsy (ESWL, Dornier Medizintechnik GmbH, Wessling Munchen, Germany) on plasma nitric oxide (NO) and cyclic nucleotides was investigated. It is known that ESWL increased plasma levels of vasoactive substances.
MATERIALS AND METHODS: A total of 28 patients undergoing ESWL for renal (14) and lower ureteral (14) stones participated in a prospective study. Peripheral blood samples were analyzed for plasma nitrite, NO metabolite, cyclic 3', 5'-guanosine monophosphate (cGMP), cyclic 3',5'-adenosine monophosphate and plasma renin activity before, immediately after, 30 and 60 minutes after ESWL. Urine samples were also analyzed for nitrite before, immediately after, 30 and 60 minutes after ESWL. Blood pressure and pulse rate were measured before and after ESWL.
RESULTS: ESWL increased mean plasma nitrite levels. Before, immediately after, 30 and 60 minutes after ESWL mean plasma nitrate plus or minus standard error in patients with renal versus lower ureteral stones was 43.6 +/- 8.5, 52.8 +/- 7.4, 54.0 +/- 8.0 and 52.2 +/- 9.1 versus 27 +/- 5.8, 24.6 +/- 4.7, 23.6 +/- 4.8 and 28.0 +/- 7.1 nM., respectively. Before, immediately after, 30 and 60 minutes after ESWL mean plasma cGMP in patients with renal versus lower ureteral stones was 1.21 +/- 0.1, 1.64 +/- 0.16, 1.52 +/- 0.12 and 1.58 +/- 0.14 versus 1.45 +/- 0.18, 1.52 +/- 0.13, 1.52 +/- 0.15 and 1.51 +/- 0.11 fmol., respectively. Cyclic 3',5'-adenosine monophosphate was not increased by ESWL in patients with renal stones. Urine nitrite increased slightly but not significantly after ESWL. Plasma cyclic nucleotides and nitrite, and urine nitrite were not changed by ESWL in patients with lower ureteral stones. Plasma renin activity decreased significantly in patients with renal stones 60 minutes after ESWL. Blood pressure and pulse rates increased mildly without statistical significance after ESWL for renal stones.
CONCLUSIONS: ESWL increases plasma nitrite and cGMP in patients with renal stones, suggesting that shock waves stimulate the NO-cGMP signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050488

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Randomized controlled trial of the efficacy of isosorbide-SR addition to current treatment in medical expulsive therapy for ureteral calculi.

Authors:  Ali Hamidi Madani; Majid Kazemzadeh; Farshid Pourreza; Maryam Shakiba; Alireza Farzan; Ahmad Asadollahzade; Samaneh Esmaeili
Journal:  Urol Res       Date:  2011-01-05

2.  The effects of shockwave on systemic concentrations of nitric oxide level, angiogenesis and osteogenesis factors in hip necrosis.

Authors:  Ching-Jen Wang; Ya-Ju Yang; Chung-Cheng Huang
Journal:  Rheumatol Int       Date:  2010-03-16       Impact factor: 2.631

3.  The protective effects of the traditional Chinese herbs against renal damage induced by extracorporeal shock wave lithotripsy: a clinical study.

Authors:  Binwu Sheng; Dalin He; Jun Zhao; Xingfa Chen; Xunyi Nan
Journal:  Urol Res       Date:  2010-07-06

4.  Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats.

Authors:  Wei Jing Liu; Heung Yong Jin; Kyung Ae Lee; Shu Hua Xie; Hong Sun Baek; Tae Sun Park
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

5.  Ways in which SWL affects oxidant/antioxidant balance.

Authors:  Erdal Yilmaz; Ahmet Haciislamoglu; Ucler Kisa; Ozlem Dogan; Ercan Yuvanc; Ertan Batislam
Journal:  Urolithiasis       Date:  2012-12-28       Impact factor: 3.436

6.  Does extracorporeal shockwave lithotripsy therapy affect thiol-disulfide homeostasis?

Authors:  Aliseydi Bozkurt; Cuma Mertoglu; Mehmet Karabakan; Gulsah Siranli; Emine Feyza Yurt; Ozcan Erel
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.